期刊文献+

依达拉奉对6-OHDA诱导的帕金森病大鼠黑质纹状体MDA、NO含量的影响 被引量:1

The influences of edaravone on the contents of MDA and NO in substantia nigra and striatum in rat model of parkin son's disease induced by 6-OHDA
下载PDF
导出
摘要 目的探讨依达拉奉对6-羟基多巴(6-OHDA)诱导的帕金森病大鼠模型的黑质纹状体系统丙二醛(MDA)、一氧化氮(NO)含量的影响。方法将实验动物分为神经生化学和组织学两组,各组分为:(1)正常对照组(n=6);(2)生理盐水(NS)对照组(n=6);(3)依达拉奉组(n=24),依达拉奉又分为0.3mg/kg 14d组(n=6),1mg/kg 14d组(n=6),3mg/kg 14d组(n=6)及3mg/kg 28d组(n=6)4个亚组。采用6-OHDA立体定位下注入SD大鼠左侧前脑内侧束制备PD模型,观察依达拉奉对PD模型大鼠的行为学改变、黑质纹状体尼氏体和MDA、NO含量的影响。结果依达拉奉呈剂量依赖性减少阿朴吗啡(APO)诱发的6-OHDA大鼠PD模型旋转次数(P<0.01),并能改善大鼠自发行为学变化;依达拉奉(3mg/kg 14d、28d)阻止了6-OHDA导致的大鼠黑质纹状体尼氏体细胞数量的减少(P<0.05);阻止了6-OHDA导致的大鼠黑质纹状体MDA、NO的增加(P<0.05)。结论依达拉奉对6-OHDA诱导的PD动物模型具有神经保护作用,能改善6-OHDA损伤大鼠的早期行为学改变,减少6-OHDA导致的大鼠黑质纹状体MDA、NO的含量增加。 Objective To investigate the influences of edaravone on the contents of malandialdehyde(MDA) and nitric oxide(NO) in substantia nigra and striatum in rat model of parkinson' s disease induced by 6-OHDA. Methods The experi- mental animals were divided into two groups including neurobiochemistry group and histolology group, each group was divided into three subgroups, they are normal controlled group ( n = 6 ), normal saline (NS) group ( n = 6) and edaravone group ( n = 24), the edaravone group was again divided into four subgroups including 0. 3mg/Kg 14d group(n =6) ,lmg/Kg 14d group(n =6) ,3mg/ Kg 14d group(n =6) ,3mg/Kg 28d group(n =6). The model of Parkinson' s disease was induced by injecting 6-OHDA into left medial forebrain bundle. The influences of edaravone on the behavior of rat,the contents of MDA,NO and nissle bodies in sub- stantia nigra and striatum were observed. Result Edaravone(3mg/kg14d,28d) dose-dependently decreased the rotation behav- iors of rat models induced by apomorphine (APO) (P 〈 0.01 ), ameliorated the spontaneous behavior, prevented the decrease of the content of nissle bodies (P 〈0.05) ,as well as prevented the increase of the contents of MDA and NO in substantia nigra and striatum in rat model of parkinson' s disease induced by 6-OHDA. Condusion Edaravone has protective effect against 6-OHDA induced neurodegeneration in rats. It can ameliorate the early change in the behavior of rat model of parkinson' s disease,and can decrease the contents of MDA and NO in substantia nigra and striatum induced by 6-OHDA.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第9期781-784,共4页 Journal of Apoplexy and Nervous Diseases
关键词 帕金森病 依达拉奉 6-OHDA 丙二醛 一氧化氮 Parkinson' s disease Edaravone 6-OHDA MDA NO
  • 相关文献

参考文献8

  • 1Stack EC, Ferro JL, Kim J, et al. Therapeutic attenuation of mito- chondrial dysfunction and oxidative stressin neurotoxin models of Par- kinson' s disease [ J ]. Biochimica et Biophysica Acta,2008,1782 : 151 - 162.
  • 2Younes MS, Frih AM, Kerkeni A, et al. Peripheral blood markers of oxidative stress in Parkinson' s disease [ J ]. Eur Neurol, 2007,58 (2) :78 -83.
  • 3The Edaravone acute brain infarction study group. Effects of a novel free radical, Edaravone( MCI-186 ) ,on acute brain infarction random- ized, placebo-controlled, doubled-blind study at multicenters the Edravone[ J ]. Cerebralvase Dis ,2003,15 ( 3 ) :222 - 229.
  • 4吴冠会,包仕尧,罗蔚峰,张志琳,霍红梅,陈应柱.依达拉奉对帕金森病大鼠多巴胺转运体保护作用的研究[J].临床神经病学杂志,2006,19(4):296-298. 被引量:10
  • 5Bredt DS, Snyder SH. Nitric oxide, a physiological messenge rmole- cule [ J ]. Annu Rev Bi-ochem, 1994,63 : 175 - 195.
  • 6Carbone DL,Moreno JA,Tjalkens RB. Nuclear factor kappa-B medi- ates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP [ J ]. Brain Res,2008,27 : 1 -9.
  • 7Hancock DB, Martin ER, Vance JM, et al. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson' s disease[J]. Neurogenetics,2008,9(4) :249 -262.
  • 8Matthews RT, Beal MF, Fallon J, et al. Mpp+ induced substantial nigra degeneration is attenuated in nNOS knock-out mouse [ J ]. Neu- robiol Dis, 1997,4 ( 2 ) : 1 14 - 121.

二级参考文献11

  • 1狄晴,葛剑青,陈道文,徐肖,陈惠玲,过燕萍,李继民,石静萍,张颖冬,李作汉.依达拉奉治疗急性脑梗死的临床观察[J].临床神经病学杂志,2004,17(3):184-186. 被引量:303
  • 2秦延昆,谢海洋.依达拉奉联合降纤酶治疗急性脑梗死的疗效观察[J].临床神经病学杂志,2005,18(3):218-219. 被引量:69
  • 3包新民 舒斯之.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.39-40.
  • 4Bahat-Stroomza M,Gilgun-Sherki Y,Offen D,et al.A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease[J].Eur J Neurosci,2005,21:637.
  • 5Watanabe T,Yuki S,Egawa M,et al.Protective effects of MCI-186 on cerebral ischemia:Possible involvement of free radical scavenging and antioxidant actions[J].J Pharmacol Exp Ther,1994,268:1597.
  • 6Tanaka M.Pharmacological and clinical profile of the free radical scavenger Edaravone as a neuroprotective agent[J].Nippon Yakurigaku Zasshi,2002,119:301.
  • 7Edaravone Acute Infarction Study Group.Effect of a novel free radical scavenger,Edaravone (MCI-186),on acute brain infarction.Randomized,placebo-controlled,double-blind study at multicenters[J].Cerebrovasc Dis,2003,15:222.
  • 8Ohta S,Iwashita Y,Takadu H,et al.Neuprotection and enhanced recovery with Edaravone after acute spinal cord injury in rats[J].Spinal,2005,30:1154.
  • 9Tetsuya Hayashi,Tatsuhiko Mori,Kiochi Sohmiya,et al.Efficacy of Edaravone,a free radical scavenger,on left ventricular function and structure in diabetes mellitus[J].J Cardiovasc Pharmacol,2003,41:923.
  • 10Mishima S,Ohta S.A synthesized radical scavenger,Edaravone ameliorates pulmonary endothelial permeability increase induced by acute oxidative stress[J].Crit Care Med,2004,32(Suppl):S122.

共引文献9

同被引文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部